Sept. 2, 2022
by Bohdana Sokolova
Biopharma insight
According to the World Health Organisation, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths …
Aug. 30, 2022
by Andrii Buvailo
Biopharma insight
Disclaimer: This post is not medical advice and is for informational purposes only. All the information contained here is related …
Aug. 25, 2022
by Bohdana Sokolova
Biopharma insight
Even though the term ‘synthetic biology’ remains foreign to an average person, the idea behind it is familiar to many. …
Aug. 24, 2022
by Joseph Pareti
Biopharma insight
AstraZeneca has achieved outstanding results in drug design using large language models applied to SMILES representation of molecules; but what are …
Aug. 18, 2022
by Bohdana Sokolova
Biopharma insight
Development of a novel drug is a tedious process that requires immense investments of resources and time - on average, …
Aug. 11, 2022
by Natalia Honchar
Biopharma insight
Nanomedicines, as it goes from the name, are nanotechnology-based drugs, used for the treatment, diagnosis or prevention of various diseases. …
Today, Insilico Medicine, a leading player in artificial intelligence (AI)-driven drug discovery and longevity research, tops up its recent $60 …
Aug. 8, 2022
by BiopharmaTrend
Biopharma insight
(This article was originally published in 2020 and updated in August 2022) Reading life science blogs is a good way …
Aug. 8, 2022
by Natalia Honchar
Biopharma insight
Auron Therapeutics, a biopharmaceutical company focused on developing therapies that target dysregulated differentiation and cellular plasticity for treating cancer, just …
Aug. 6, 2022
by Bohdana Sokolova
Biopharma insight
New Jersey-based Anima Biotech, a leader in the discovery of small molecule mRNA drugs and their mechanisms of action (MOAs) …
Aug. 5, 2022
by Natalia Honchar
Biopharma insight
Owkin, a biotech startup that uses artificial intelligence (AI) for precision cancer therapy development is partnering with scientists from the …
Aug. 3, 2022
by Natalia Honchar
Biopharma insight
Ginkgo Bioworks, the biotech firm with a platform for cell programming, recently entered into a definitive agreement to acquire a …